Topic Highlight
Copyright ©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Sep 21, 2007; 13(35): 4690-4698
Published online Sep 21, 2007. doi: 10.3748/wjg.v13.i35.4690
Non-HFE haemochromatosis
Daniel F Wallace, V Nathan Subramaniam
Daniel F Wallace, V Nathan Subramaniam, Membrane Transport Laboratory, The Queensland Institute of Medical Research, Brisbane, Queensland, Australia
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. V Nathan Subramaniam, Membrane Transport Laboratory, The Queensland Institute of Medical Research, 300 Herston Road, Herston, Brisbane, QLD 4006 Australia. nathan.subramaniam@qimr.edu.au
Telephone: + 617-3362-0179 Fax: + 617-3362-0191
Received: March 30, 2007
Revised: April 23, 2007
Accepted: April 29, 2007
Published online: September 21, 2007
Abstract

Non-HFE hereditary haemochromatosis (HH) refers to a genetically heterogeneous group of iron overload disorders that are unlinked to mutations in the HFE gene. The four main types of non-HFE HH are caused by mutations in the hemojuvelin, hepcidin, transferrin receptor 2 and ferroportin genes. Juvenile haemochromatosis is an autosomal recessive disorder and can be caused by mutations in either hemojuvelin or hepcidin. An adult onset form of HH similar to HFE-HH is caused by homozygosity for mutations in transferrin receptor 2. The autosomal dominant iron overload disorder ferroportin disease is caused by mutations in the iron exporter ferroportin. The clinical characteristics and molecular basis of the various types of non-HFE haemochromatosis are reviewed. The study of these disorders and the molecules involved has been invaluable in improving our understanding of the mechanisms involved in the regulation of iron metabolism.

Keywords: Haemochromatosis, Iron overload, Non-HFE, Juvenile haemochromatosis, Hemojuvelin, Hepcidin, Transferrin receptor 2, Ferroportin